Form 4 for GDRX GoodRx Holdings, Inc.

Accepted 2021-08-11 00:00:00 ET · period of report 2021-08-09 · accession 0000899243-21-032504 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
D	2021-08-11	2021-08-09	GDRX	Azad Babak	See Remarks	M - OptEx	$5.94	+6,250	6,250	New	+$37.1K
D	2021-08-11	2021-08-09	GDRX	Azad Babak	See Remarks	S - Sale+OE	$31.37	-6,250	0	-100%	-$196.1K
D	2021-08-11	2021-08-09	GDRX	Azad Babak	See Remarks	M - OptEx	$0.00	-6,250	331.2K	-2%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A Common Stock	2021-08-09	M	A	6,250	$5.94	6,250	D	—	—
2	Common	Class A Common Stock	2021-08-09	S	D	6,250	$31.37	0	D	—	—	(F2) This price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.88 to $31.69. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3	Derivative	Stock Option (Right to Buy)	2021-08-09	M	D	6,250	$0.00	331,250	D	$5.94 · — to 2030-01-30	6,250 Class A Common Stock	(F3) The option has vested and became exercisable or will vest and become exercisable with respect to the original 600,000 underlying shares of Class A common stock in equal monthly installments over a four year period that commenced on October 9, 2019.